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Background: The effects of screening for increased carotid intima-media thickness (CIMT) and carotid plaque (CP) on patient health-related 
behaviors (HRBs) are unclear. We prospectively studied the effects of carotid ultrasound (CUS) screening at the time of an office visit on HRBs and 
patient perceptions of cardiovascular disease (CVD) risk.
Methods: Subjects were ≥40 years old and had ≥1 CVD risk factor. They were patients from 5 non-academic, community medical practices 
at which physicians and staff were taught to measure CIMT and identify CP. Subjects completed questionnaires regarding CVD knowledge and 
behavioral intentions before and immediately after the office visit when they were scanned. They were surveyed again after 30 days, to determine 
actual changes in CVD knowledge and HRBs. Advanced atherosclerosis (AdvAthero) was defined as CIMT ≥75th percentile (for age, sex, and race) or 
CP presence. Hierarchical logistic regression models with patient responses nested under physician were adjusted for risk factors and demographics; 
odds ratios (OR, 95% confidence intervals).
Results: CUS was performed on 355 subjects [53.6 (7.9) years old, 2.3 (0.9) risk factors]; 266 (74.9%) had AdvAthero. Immediately after CUS, 
subjects described increased ability to change HRBs (p=0.002), regardless of their test results.  Subjects with AdvAthero were more likely to report 
an increased perception of CVD risk (OR 4.1 [2.0-8.6], p<0.001), intentions to reach exercise goals (OR 2.3 [1.2-4.2], p=0.008), make healthy 
dietary changes (OR 3.0 [1.9-4.6], p<0.001), and quit smoking (OR 5.0 [1.3-19.8], p=0.021). After 30 days, 34% increased exercise frequency, 62% 
made dietary changes, and 37% reported weight loss. The presence of AdvAthero predicted reduced dietary sodium (OR 1.5 [1.2-1.8], p=0.002) and 
increased fiber (OR 1.6 [1.1-2.26], p=0.022) intake, with a trend towards dietary cholesterol reduction (OR 1.5 [0.9-2.5], p=0.077).
Conclusions: Regardless of the results, CUS screening increased perceived ability to change behavior. The presence of AdvAthero predicted 
successful dietary changes after 30 days. 
